Assessment reveals improved pump performance and decreased hemolysis risk in ECMO therapy, suggesting enhanced safety.
This study focuses on the evaluation of a modernized impeller for the RotaFlow centrifugal pump (Maquet, Germany), carried out as part of efforts to design a domestic counterpart. The proposed impeller features a combination of primary elongated blades, responsible for generating the majority of pressure, and secondary shortened blades. The investigation examined pump performance under extracorporeal membrane oxygenation (ECMO) therapy conditions at a pressure of 350 mmHg and flow rate of 5 L/min. Computational analyses were conducted to evaluate fluid flow parameters associated with hemolysis risk. The optimized impeller demonstrated a significant increase in low tangential stress zones (<10 Pa), reduced exposure time, and a lower hemolysis index. Comparative mathematical modeling and bench testing with donor blood confirmed the improved hemodynamic performance of the redesigned impeller over the original configuration.
No takes yet. Share an insight, caveat, or question.
Kuleshov et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: